Replies to post #535143 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

I consulted my own common sense on this point. Two simple thought experiments were enlightening for me personally:

Imagine having recurrent GBM. Would I want murcidencel?

Imagine the FDA Oncologic Drugs Advisory Committee voting on this question: Is the benefit-risk profile of murcidencel (DCVax-L) favorable in patients with recurrent GBM?